These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 28322030)
1. Melatonin and IL-25 modulate apoptosis and angiogenesis mediators in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumour cells. Gelaleti GB; Borin TF; Maschio-Signorini LB; Moschetta MG; Hellmén E; Viloria-Petit AM; Zuccari DAPC Vet Comp Oncol; 2017 Dec; 15(4):1572-1584. PubMed ID: 28322030 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of melatonin, IL-25 and siIL-17B in tumorigenesis-associated properties of breast cancer cell lines. Gelaleti GB; Borin TF; Maschio-Signorini LB; Moschetta MG; Jardim-Perassi BV; Calvinho GB; Facchini MC; Viloria-Petit AM; de Campos Zuccari DAP Life Sci; 2017 Aug; 183():98-109. PubMed ID: 28624391 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of melatonin treatment in primary culture of canine mammary tumors. Lopes JR; Maschio LB; Jardim-Perassi BV; Moschetta MG; Ferreira LC; Martins GR; Gelaleti GB; De Campos Zuccari DA Oncol Rep; 2015 Jan; 33(1):311-9. PubMed ID: 25384569 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Angiogenesis Process after Metformin and LY294002 Treatment in Mammary Tumor. Moschetta MG; Leonel C; Maschio-Signorini LB; Borin TF; Gelaleti GB; Jardim-Perassi BV; Ferreira LC; Sonehara NM; Carvalho LGS; Hellmén E; de Campos Zuccari DAP Anticancer Agents Med Chem; 2019; 19(5):655-666. PubMed ID: 30569877 [TBL] [Abstract][Full Text] [Related]
5. Melatonin decreases in vitro viability and migration of spheres derived from CF41.Mg canine mammary carcinoma cells. Serrano C; Guzmán S; Arias JI; Torres CG BMC Vet Res; 2019 Nov; 15(1):390. PubMed ID: 31684950 [TBL] [Abstract][Full Text] [Related]
6. Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines. Gonçalves Ndo N; Colombo J; Lopes JR; Gelaleti GB; Moschetta MG; Sonehara NM; Hellmén E; Zanon Cde F; Oliani SM; Zuccari DA PLoS One; 2016; 11(3):e0150407. PubMed ID: 26934679 [TBL] [Abstract][Full Text] [Related]
7. Anti-tumour effect of metformin in canine mammary gland tumour cells. Saeki K; Watanabe M; Tsuboi M; Sugano S; Yoshitake R; Tanaka Y; Ong SM; Saito T; Matsumoto K; Fujita N; Nishimura R; Nakagawa T Vet J; 2015 Aug; 205(2):297-304. PubMed ID: 25981932 [TBL] [Abstract][Full Text] [Related]
8. Effect of the VP3 gene of chicken anemia virus on canine mammary tumor cells. Lee JJ; Chen PB; Yang SH; Cheng CH; Chueh LL; Pang VF; Hsiao M; Lin CT Am J Vet Res; 2007 Apr; 68(4):411-22. PubMed ID: 17397298 [TBL] [Abstract][Full Text] [Related]
9. Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27. Bakirel T; Alkan FÜ; Üstüner O; Çinar S; Yildirim F; Erten G; Bakirel U J Vet Med Sci; 2016 May; 78(4):657-68. PubMed ID: 26822118 [TBL] [Abstract][Full Text] [Related]
10. Canine mammary tumors contain cancer stem-like cells and form spheroids with an embryonic stem cell signature. Ferletta M; Grawé J; Hellmén E Int J Dev Biol; 2011; 55(7-9):791-9. PubMed ID: 22161835 [TBL] [Abstract][Full Text] [Related]
11. Cellular effects of a turmeric root and rosemary leaf extract on canine neoplastic cell lines. Levine CB; Bayle J; Biourge V; Wakshlag JJ BMC Vet Res; 2017 Dec; 13(1):388. PubMed ID: 29237458 [TBL] [Abstract][Full Text] [Related]
12. Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells. Foong JN; Selvarajah GT; Rasedee A; Rahman HS; How CW; Beh CY; Teo GY; Ku CL Biomed Res Int; 2018; 2018():8691569. PubMed ID: 30410940 [TBL] [Abstract][Full Text] [Related]
13. Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours. Raposo TP; Pires I; Carvalho MI; Prada J; Argyle DJ; Queiroga FL Vet Comp Oncol; 2015 Dec; 13(4):464-74. PubMed ID: 24119241 [TBL] [Abstract][Full Text] [Related]
14. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors. Guillemette S; Rico C; Godin P; Boerboom D; Paquet M J Mammary Gland Biol Neoplasia; 2017 Sep; 22(3):203-214. PubMed ID: 28822004 [TBL] [Abstract][Full Text] [Related]
15. Transcriptomic signature of cell lines isolated from canine mammary adenocarcinoma metastases to lungs. Król M; Polańska J; Pawłowski KM; Turowski P; Skierski J; Majewska A; Ugorski M; Morty RE; Motyl T J Appl Genet; 2010; 51(1):37-50. PubMed ID: 20145299 [TBL] [Abstract][Full Text] [Related]
16. Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds. Raposo LR; Roma-Rodrigues C; Jesus J; Martins LMDRS; Pombeiro AJ; Baptista PV; Fernandes AR Vet Comp Oncol; 2017 Dec; 15(4):1537-1542. PubMed ID: 28150469 [TBL] [Abstract][Full Text] [Related]
18. Phenotypic screening of a library of compounds against metastatic and non-metastatic clones of a canine mammary gland tumour cell line. Saeki K; Watanabe M; Michishita M; Tsuboi M; Sugano S; Yoshitake R; Murai K; Tanaka Y; Ong SM; Saito T; Matsumoto K; Fujita N; Nishimura R; Nakagawa T Vet J; 2015 Aug; 205(2):288-96. PubMed ID: 25975851 [TBL] [Abstract][Full Text] [Related]
19. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer. Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848 [TBL] [Abstract][Full Text] [Related]
20. Myoepithelial cells in canine mammary tumours. Sánchez-Céspedes R; Millán Y; Guil-Luna S; Reymundo C; Espinosa de Los Monteros A; Martín de Las Mulas J Vet J; 2016 Jan; 207():45-52. PubMed ID: 26639832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]